Macular Degeneration and Other Retinal Diseases Market

Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands.
Macular Degeneration and Other Retinal Diseases Market contains market size and forecasts of Macular Degeneration (AMD) and Other Retinal Diseases in Global, including the following market information:
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Macular Degeneration (AMD) and Other Retinal Diseases market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Macular Degeneration Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Macular Degeneration (AMD) and Other Retinal Diseases include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma, Merck, Allergan, Santen Pharmaceutical and GlaxoSmithKline Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Macular Degeneration (AMD) and Other Retinal Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, by Type, 2021 (%)
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy(DR)
Retinal Vein Occlusion
Wet Age-Related Macular Degeneration (wAMD)
Dry Age-Related Macular Degeneration (dAMD)
Other
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Macular Degeneration (AMD) and Other Retinal Diseases revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Macular Degeneration (AMD) and Other Retinal Diseases revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC